Bioresorbable Vascular Scaffold Market By Material Type (Polymer Based Stents, Metallic Stents), By Disease Indication (Coronary Heart Disease, Peripheral Artery Disease, Other Cardiovascular Diseases), By End-user (Hospitals, Specialty Clinics, Ambulatory Surgical Centers) - Growth, Future Prospects & Competitive Analysis, 2019 – 2027

"Bioresorbable vascular scaffold market to exhibit dynamic growth during the forecast period"

The global bioresorbable vascular scaffold market is growing proficiently, expected to grow at a CAGR of 10.3%. Worldwide, the increasing prevalence of coronary heart-related disorders and other cardiovascular disorders will drive the growth of the market. Increasing awareness about new bioabsorbable technology to overcome the limitations by permanent metallic endoprosthesis along with the launch of advanced cardiac stents with integrated solutions will boost the overall demand in the developed nations. Top-quality improved biomaterials (metal or polymer) are few of the major factors driving the demand of bioresorbable vascular scaffold market on a global scale.

Market Synopsis

Get a sample copy for more information

"Polymer based stents segment expected to register higher growth by the end of 2027"

Advancement in polymer bioabsorbable scaffolds along with the development in the field of metal alloys will drive the market growth. These stents, without any external intervention prevent restenosis and thrombosis. For e.g. Magmaris, it is the first clinically proven coronary resorbable magnesium alloy scaffold, released by Biotronik. Advancement in polymer technology along with biological vascular scaffolds will enhance market growth. In July 2016, the U.S FDA approved Absorb GT1 bioresorbable vascular scaffold system (BVS) made from a polymer called poly (L-lactide). New product development, rising hospital admissions for ischemic heart disease along with by-pass cardiac surgical procedures will drive the market growth on a global scale.

Get a sample copy for more information

"Coronary heart diseases to witness a significant CAGR"

Growing hospital admissions for coronary heart disease and its surgical treatment generated maximum market share in 2018. Moreover, huge patient pool with cardiovascular-related disorders on a global scale will drive the market growth globally. In 2017, according to statistics by WHO, cardiovascular disease accounted for more than 17.5 million deaths globally, majorly due to heart attack and stroke. Additionally, the increasing prevalence for ischemic heart disease, acute coronary syndrome, and peripheral artery related conditions will drive the overall demand for bioresorbable vascular scaffold market. Advancement in synthetic technology, FDA approval for advanced products, and increasing geriatric and obese population offers a huge advantage in the global stent industry.

Get a sample copy for more information

"Increased research and development with strong product pipelines in the developed regions"

Major players in the bioresorbable vascular scaffold market are Cook Medical, Medtronic, plc., Abbott Laboratories, Stentys SA, C. R. Bard, Inc., MAQUET Holding B.V. & Co. KG, Boston Scientific Corporation, Terumo Corporation, W.L. Gore & Associates, Boston Scientific Corporation, AngioDynamics, Inc., Vygon Ltd. and others. Major enterprises are developing new stents with advanced mesh technologies with combined biological solutions. Merger and acquisitions, partnerships and improved R&D on bioresorbable vascular scaffolds will drive the market growth in the near future.

Historical & Forecast Period

This study report represents analysis for each segment from 2017 to 2027 considering 2018 to be the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period from 2019 to 2027.

Report Scope by Segments

Market Segmentation

The current report also comprehends qualitative and qualitative market valuation factors such as key market drivers, market trends, restraints and opportunities that gives a better market understanding of the overall bioresorbable vascular scaffold market. Additionally, the global report also comprises graphical representation of competitive landscape based on their market initiatives and strategies, product portfolio and business strengths.

Key questions answered in this report

• What are the current market trends and dynamics in the bioresorbable vascular scaffold market and valuable opportunities for emerging players?
• Which segment accounts for the fastest CAGR during the forecast period?
• Which material type segment holds a larger market share and why?
• Are low and middle-income economies investing in the bioresorbable vascular scaffold market?
• What is the market trend and dynamics in emerging markets such as Asia Pacific, Latin America and Middle East & Africa?

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.4. Market Segmentation

2. Executive Summary
2.1. Market Snapshot: Global BVS Market
2.2. Global BVS Market, by Material Type, 2018 (US$ Mn)
2.3. Global BVS Market, by Disease Indication, 2018 (US$ Mn)
2.4. Global BVS Market, by End-user, 2018 (US$ Mn)
2.5. Global BVS Market, by Geography, 2018 (US$ Mn)

3. Market Dynamics
3.1. Introduction
3.1.1. Global BVS Market Value, 2017-2027, (US$ Mn)
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.2. Market Restraints
3.3. Attractive Investment Proposition, by Geography, 2018
3.4. Market Positioning of Key Players, 2018
3.4.1. Major Strategies Adopted by Key Players

4. Global Bioresorbable Vascular Scaffold (BVS) Market, by Material Type , 2017-2027 (US$ Mn)
4.1. Overview
4.2. Polymer Based Stents
4.3. Metallic Stents

5. Global Bioresorbable Vascular Scaffold (BVS) Market, by Disease Indication, 2017-2027 (US$ Mn)
5.1. Overview
5.2. Coronary Heart Disease
5.3. Peripheral Artery Disease
5.4. Other Cardiovascular Diseases

6. Global Bioresorbable Vascular Scaffold (BVS) Market, by End-user, 2017-2027 (US$ Mn)
6.1. Hospitals
6.2. Specialty Clinics
6.3. Ambulatory Surgical Centers

7. North America Bioresorbable Vascular Scaffold (BVS) Market Analysis, 2017-2027 (US$ Mn)
7.1. Overview
7.1.1. North America BVS Market Value and Growth, 2017-2027, (US$ Mn)
7.2. North America BVS Market Value, By Material Type, 2017-2027 (US$ Mn)
7.2.1. Market Analysis
7.3. North America BVS Market Value, By Disease Indication, 2017-2027 (US$ Mn)
7.3.1. Market Analysis
7.4. North America BVS Market Value, By End-user, 2017-2027 (US$ Mn)
7.4.1. Market Analysis
7.5. North America BVS Market Value, By Region/Country, 2017-2027 (US$ Mn)
7.5.1. Market Analysis
7.5.2. U.S.
7.5.3. Rest of North America

8. Europe Bioresorbable Vascular Scaffold (BVS) Market Analysis, 2017-2027 (US$ Mn)
8.1. Overview
8.1.1. Europe BVS Market Value and Growth, 2017-2027, (US$ Mn)
8.2. Europe BVS Market Value, By Material Type, 2017-2027 (US$ Mn)
8.2.1. Market Analysis
8.3. Europe BVS Market Value, By Disease Indication, 2017-2027 (US$ Mn)
8.3.1. Market Analysis
8.4. Europe BVS Market Value, By Component, 2017-2027 (US$ Mn)
8.4.1. Market Analysis
8.5. Europe BVS Market Value, By Connectivity Type, 2017-2027 (US$ Mn)
8.5.1. Market Analysis
8.6. Europe BVS Market Value, By End-user, 2017-2027 (US$ Mn)
8.6.1. Market Analysis
8.7. Europe BVS Market Value, By Region/Country, 2017-2027 (US$ Mn)
8.7.1. Market Analysis
8.7.2. U.K.
8.7.3. Germany
8.7.4. France
8.7.5. Rest of Europe

9. Asia Pacific Bioresorbable Vascular Scaffold (BVS) Market Analysis, 2017-2027 (US$ Mn)
9.1. Overview
9.1.1. Asia Pacific BVS Market Value and Growth, 2017-2027, (US$ Mn)
9.2. Asia Pacific BVS Market Value, By Material Type, 2017-2027 (US$ Mn)
9.2.1. Market Analysis
9.3. Asia Pacific BVS Market Value, By Disease Indication, 2017-2027 (US$ Mn)
9.3.1. Market Analysis
9.4. Asia Pacific BVS Market Value, By Component, 2017-2027 (US$ Mn)
9.4.1. Market Analysis
9.5. Asia Pacific BVS Market Value, By Connectivity Type, 2017-2027 (US$ Mn)
9.5.1. Market Analysis
9.6. Asia Pacific BVS Market Value, By End-user, 2017-2027 (US$ Mn)
9.6.1. Market Analysis
9.7. Asia Pacific BVS Market Value, By Region/Country, 2017-2027 (US$ Mn)
9.7.1. Market Analysis
9.7.2. Japan
9.7.3. China
9.7.4. India
9.7.5. Rest of Asia Pacific

10. Rest of the World Bioresorbable Vascular Scaffold (BVS) Market Analysis, 2017-2027 (US$ Mn)
10.1. Overview
10.1.1. Rest of the World BVS Market Value and Growth, 2017-2027, (US$ Mn)
10.2. Rest of the World BVS Market Value, By Material Type, 2017-2027 (US$ Mn)
10.2.1. Market Analysis
10.3. Rest of the World BVS Market Value, By Disease Indication, 2017-2027 (US$ Mn)
10.3.1. Market Analysis
10.4. Rest of the World BVS Market Value, By Component, 2017-2027 (US$ Mn)
10.4.1. Market Analysis
10.5. Rest of the World BVS Market Value, By Connectivity Type, 2017-2027 (US$ Mn)
10.5.1. Market Analysis
10.6. Rest of the World BVS Market Value, By End-user, 2017-2027 (US$ Mn)
10.6.1. Market Analysis
10.7. Rest of the World BVS Market Value, By Region, 2017-2027 (US$ Mn)
10.7.1. Market Analysis
10.7.2. Middle East & Africa
10.7.3. Latin America

11. Company Profiles
11.1. Cook Medical
11.2. Medtronic, plc.
11.3. Abbott Laboratories
11.4. Stentys SA
11.5. C. R. Bard, Inc.
11.6. MAQUET Holding B.V. & Co. KG
11.7. Boston Scientific Corporation
11.8. Terumo Corporation
11.9. W.L. Gore & Associates
11.10. Boston Scientific Corporation
11.11. AngioDynamics, Inc.
11.12. Vygon Ltd.

* Here we are using BVS as a short form of Bioresorbable Vascular Scaffold

FIG. 1 Global Bioresorbable Vascular Scaffold (BVS) Market: Research Methodology
FIG. 2 Market Size Estimation – Top-Down and Bottom Up Approach
FIG. 3 Global BVS Market Segmentation
FIG. 4 Global BVS Market, by Material Type, 2018 (US$ Mn)
FIG. 5 Global BVS Market, by Disease Indication, 2018 (US$ Mn)
FIG. 6 Global BVS Market, by End-user, 2018 (US$ Mn)
FIG. 7 Global BVS Market, by Geography, 2018 (US$ Mn)
FIG. 8 Global BVS Market Value, 2017-2027, (US$ Mn) and (Y-o-Y%)
FIG. 9 Attractive Investment Proposition, by Geography, 2018
FIG. 10 Global Market Positioning of Key BVS Providers, 2018
FIG. 11 Global BVS Market Value Share, by Material Type, 2018 & 2027 (Value %)
FIG. 12 Global Polymer Based Stents Market Value, 2017-2027, (US$ Mn)
FIG. 13 Global Metallic Stents Market Value, 2017-2027, (US$ Mn)
FIG. 14 Global BVS Market Value Share, by Disease Indication, 2018 & 2027 (Value %)
FIG. 15 Global Coronary Heart Disease Market Value, 2017-2027, (US$ Mn)
FIG. 17 Global Peripheral Artery Disease Market Value, 2017-2027, (US$ Mn)
FIG. 18 Global BVS Market Value for Other Cardiovascular Diseases, 2017-2027, (US$ Mn)
FIG. 19 Global BVS Market Value Share, by End-user, 2018 & 2027 (Value %)
FIG. 20 Global BVS Market Value for Hospitals, 2017-2027, (US$ Mn)
FIG. 21 Global BVS Market Value for Clinics, 2017-2027, (US$ Mn)
FIG. 22 Global BVS Market Value for Ambulatory Surgical Centers, 2017-2027, (US$ Mn)
FIG. 23 North America BVS Market Value, 2017-2027, (US$ Mn)
FIG. 24 Europe BVS Market Value, 2017-2027, (US$ Mn)
FIG. 25 Asia Pacific BVS Market Value, 2017-2027, (US$ Mn)
FIG. 26 RoW BVS Market Value, 2017-2027, (US$ Mn)

TABLE 1 Market Snapshot: Global Bioresorbable Vascular Scaffold (BVS) Market Value
TABLE 2 Impact Indicators
TABLE 3 Impact Analysis of Drivers and Restraints
TABLE 4 Global BVS Market, by Material Type, 2017-2027 (US$ Mn)
TABLE 5 Global BVS Market, by Disease Indication, 2017-2027 (US$ Mn)
TABLE 6 Global BVS Market, by End-user, 2017 - 2027 (US$ Mn)
TABLE 7 Global BVS Market, by Geography, 2017-2027 (US$ Mn)
TABLE 8 North America BVS Market, by Material Type, 2017-2027 (US$ Mn)
TABLE 9 North America BVS Market, by Disease Indication, 2017-2027 (US$ Mn)
TABLE 10 North America BVS Market, by End-user, 2017 - 2027 (US$ Mn)
TABLE 11 North America BVS Market Value, by Region/Country, 2017-2027 (US$ Mn)
TABLE 12 Europe BVS Market, by Material Type, 2017-2027 (US$ Mn)
TABLE 13 Europe BVS Market, by Disease Indication, 2017-2027 (US$ Mn)
TABLE 14 Europe BVS Market, by End-user, 2017 - 2027 (US$ Mn)
TABLE 15 Europe BVS Market Value, by Region/Country, 2017-2027 (US$ Mn)
TABLE 16 Asia Pacific BVS Market, by Material Type, 2017-2027 (US$ Mn)
TABLE 17 Asia Pacific BVS Market, by Disease Indication, 2017 -2027 (US$ Mn)
TABLE 18 Asia Pacific BVS Market, by End-user, 2017 - 2027 (US$ Mn)
TABLE 19 Asia Pacific BVS Market Value, by Region/Country, 2017-2027 (US$ Mn)
TABLE 20 Rest of the World BVS Market, by Material Type, 2017-2027 (US$ Mn)
TABLE 21 Rest of the World BVS Market, by Disease Indication, 2017-2027 (US$ Mn)
TABLE 22 Rest of the World BVS Market, by End-user, 2017 - 2027 (US$ Mn)
TABLE 23 Rest of the World BVS Market Value, by Region, 2017-2027 (US$ Mn)
TABLE 24 Cook Medical.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 25 Medtronic, plc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 26 Abbott Laboratories: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 27 Stentys SA: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 28 C. R. Bard, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 29 MAQUET Holding B.V. & Co. KG: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 30 Boston Scientific Corporation: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 31 Terumo Corporation: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 32 W.L. Gore & Associates.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 33 Boston Scientific Corporation: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 34 AngioDynamics, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 35 Vygon Ltd.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)